Biocon shares rise after ₹640-cr block deal, Brazil pact

Biocon shares gained over 3% after a ₹635-640 crore block deal involving about 1.66 crore shares, with True North's Active Pine LLP reportedly exiting its position. Investor sentiment was also supported by a 10-year Brazil supply agreement for Pertuzumab, covering the country's public healthcare market.